Thursday, September 22, 2016

Buserelin




In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L02AE01

CAS registry number (Chemical Abstracts Service)

0057982-77-1

Chemical Formula

C60-H86-N16-O13

Molecular Weight

1239

Therapeutic Categories

Antineoplastic agent

Gonadotropin releasing hormone (GnRH) agonist

Chemical Name

Luteinizing hormone-releasing factor (pig), 6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-10-deglycinamide-

Foreign Names

  • Buserelinum (Latin)
  • Buserelin (German)
  • Buséréline (French)
  • Buserelina (Spanish)

Generic Names

  • Buserelin (OS: BAN)
  • Buserelina (OS: DCIT)
  • Buséréline (OS: DCF)
  • Hoe 766 (IS)
  • S 746766 (IS)
  • Buserelin (PH: BP 2010, Ph. Eur. 6)
  • Buséréline (PH: Ph. Eur. 6)
  • Buserelinum (PH: Ph. Eur. 6)
  • Buserelin Acetate (OS: JAN, USAN, BANM)

Brand Names

  • Receptal (veterinary use)
    Hoechst Roussel Vet, Portugal; Hoechst Vet, Ireland; Intervet, United Kingdom


  • Suprefact
    Aventis, Singapore


  • Bigonist
    Sanofi-Aventis, France


  • Buserecur
    Fuji Yakuhin, Japan


  • Buserelin aniMedica (veterinary use)
    Animedica, Austria; Animedica, Germany; Animedica, Poland


  • Buserol (veterinary use)
    Gräub, Switzerland


  • Busol (veterinary use)
    Laboratoires Biové, France


  • Fuset
    Mylan Pharmaceutical, Japan


  • Itorelin
    ILSIto Life Sciences, Japan


  • Metrelef
    Ferring, Germany


  • Profact
    Sanofi-Aventis, Germany


  • Receptal (veterinary use)
    Intervet, Austria; Intervet, Belgium; Intervet, Germany; Intervet, Finland; Intervet, Italy; Intervet, Netherlands; Intervet, Norway; Intervet, Sweden; Intervet, South Africa; Intervet / Schering-Plough Animal Health, New Zealand; Intervet/Schering-Plough Animal Health, Australia; Veterinaria, Switzerland


  • Réceptal (veterinary use)
    Intervet, France


  • Suprecur
    Sanofi Aventis, Japan; Sanofi-Aventis, Austria; Sanofi-Aventis, Denmark; Sanofi-Aventis, Finland; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Hong Kong; Sanofi-Aventis, Ireland; Sanofi-Aventis, Norway; Sanofi-Aventis, Sweden; Sanofi-Aventis, Turkey


  • Suprefact Nasal
    Sanofi-Aventis S.A., Spain


  • Suprefact
    Aventis, Israel; Aventis, Iceland; Aventis, Luxembourg; Aventis, Serbia; Aventis, Slovakia; Aventis, South Africa; Dr. Fisher, Netherlands; Euro, Netherlands; Medcor, Netherlands; Sanofi-Aventis, Argentina; Sanofi-Aventis, Austria; Sanofi-Aventis, Belgium; Sanofi-Aventis, Bahrain; Sanofi-Aventis, Canada; Sanofi-Aventis, Denmark; Sanofi-Aventis, Egypt; Sanofi-Aventis, Finland; Sanofi-Aventis, France; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, Greece; Sanofi-Aventis, Hungary; Sanofi-Aventis, Ireland; Sanofi-Aventis, Iraq; Sanofi-Aventis, Iran; Sanofi-Aventis, Italy; Sanofi-Aventis, Kuwait; Sanofi-Aventis, Lebanon; Sanofi-Aventis, Malta; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Netherlands; Sanofi-Aventis, New Zealand; Sanofi-Aventis, Oman; Sanofi-Aventis, Qatar; Sanofi-Aventis, Saudi Arabia; Sanofi-Aventis, Sweden; Sanofi-Aventis, Singapore; Sanofi-Aventis, Syria; Sanofi-Aventis, Thailand; Sanofi-Aventis, Turkey; Sanofi-Aventis, Yemen; Sanofi-Aventis - Produtos farmacêuticos, S.A., Portugal; Sanofi-Aventis S.A., Spain; Sanofi-Synthelabo, United Arab Emirates; Sanofi-Synthelabo, Jordan


  • Suprefact Depot
    Aventis, Brazil; Sanofi-Aventis, Austria; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Hungary; Sanofi-Aventis, Israel; Sanofi-Aventis, Norway; Sanofi-Aventis, Sweden; Sanofi-Aventis - Produtos farmacêuticos, S.A., Portugal; Sanofi-Aventis S.A., Spain


  • Supremon
    Sanofi-Aventis, Taiwan

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

1 comment:

  1. Buserelin is a potent LHRH agonist. After a transient increase, continuous administration results in downregulation of LH and FSH levels followed by a suppression of ovarian and testicular steroid biosynthesis. Buserelin Acetate

    ReplyDelete